| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8585 |
| Human Intestinal Absorption | HIA+ | 0.9951 |
| Caco-2 Permeability | Caco2- | 0.5292 |
| P-glycoprotein Substrate | Non-substrate | 0.8498 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.5971 |
| Non-inhibitor | 0.9958 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9368 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7635 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8293 |
| CYP450 2D6 Substrate | Non-substrate | 0.7634 |
| CYP450 3A4 Substrate | Substrate | 0.5153 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.6100 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.5493 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8989 |
| CYP450 2C19 Inhibitor | Inhibitor | 0.5445 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.6142 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.5744 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9542 |
| Non-inhibitor | 0.8978 |
| AMES Toxicity | Non AMES toxic | 0.6656 |
| Carcinogens | Non-carcinogens | 0.6649 |
| Fish Toxicity | High FHMT | 0.9920 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9804 |
| Honey Bee Toxicity | High HBT | 0.8932 |
| Biodegradation | Not ready biodegradable | 0.8263 |
| Acute Oral Toxicity | I | 0.7738 |
| Carcinogenicity (Three-class) | Non-required | 0.6621 |